Hydrolysis‐Sensitive Dithiolethione Prodrug Micelles
Source abstract
Abstract
Prodrug micelles carrying 5‐(4‐hydroxyphenyl)‐3H‐1,2‐dithiole‐3‐thione (ADT‐OH), a compound possessing chemopreventive properties, are prepared from amphiphilic block copolymers linking ADT‐OH via an ester bond using glycine (PAM‐PGlyADT) and isoleucine linkers (PAM‐PIleADT). The release of ADT‐OH from the PAM‐PIleADT micelles is much slower than the PAM‐PGlyADT micelles. The PAM‐PGlyADT micelles show comparable toxicity with ADT‐OH in different cancer cell lines, whereas the PAM‐PIleADT micelles are not toxic up to 400 µM. This ADT‐ester prodrug micelle approach enables to modulate the release rate of ADT‐OH and thus might find application in cancer therapy and prevention.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Metal-Organic Frameworks: Synthesis and Applications · Sulfur Compounds in Biology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Frontier Research Base for Young Researchers and Department of Applied Chemistry Graduate School of Engineering Osaka University 2‐1 Yamadaoka Suita Osaka 565‐0871 Japan
Department of Applied Chemistry Graduate School of Engineering Osaka University 2‐1 Yamadaoka Suita Osaka 565‐0871 Japan
Frontier Research Center and Department of Applied Chemistry Graduate School of Engineering Osaka University 2‐1 Yamadaoka Suita Osaka 565‐0871 Japan
Funding
Grant-in-Aid for Challenging Exploratory Research
References (27)
Show source-provided references
1. 10.1158/1535-7163.MCT-08-062510.1158/1535-7163.MCT-08-0625 ↗
2. Reddy B. S. · Cancer Res. · 1993 · 53 · 3493
3. 10.1007/s00702-005-0350-010.1007/s00702-005-0350-0 ↗
4. 10.1016/S0027-5107(01)00190-710.1016/S0027-5107(01)00190-7 ↗
5. 10.1074/jbc.M21189820010.1074/jbc.M211898200 ↗
6. Christen M. O. · 1995 · 324
7. Christen M.‐O. · 1995 · 316
8. 10.1038/nrd242510.1038/nrd2425 ↗
9. 10.1021/bc500150s10.1021/bc500150s ↗
10. 10.1016/j.bcp.2011.12.01810.1016/j.bcp.2011.12.018 ↗
11. 10.1039/c3md00362k10.1039/c3md00362k ↗
12. 10.1021/jm100425v10.1021/jm100425v ↗
13. 10.1038/nrd108810.1038/nrd1088 ↗
14. 10.1002/polc.507051011110.1002/polc.5070510111 ↗
15. 10.1016/0378-5173(92)90176-310.1016/0378-5173(92)90176-3 ↗
16. 10.1038/nrc195810.1038/nrc1958 ↗
17. 10.1021/bc00016a00710.1021/bc00016a007 ↗
18. 10.1016/S0065-2571(00)00013-310.1016/S0065-2571(00)00013-3 ↗
19. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
20. Jorgensen K. E. · Am. J. Physiol. · 1979 · 236 · F10310.1152/ajpcell.1979.236.3.C103 ↗
21. 10.1002/adhm.20140024910.1002/adhm.201400249 ↗
22. 10.1016/j.freeradbiomed.2006.12.01110.1016/j.freeradbiomed.2006.12.011 ↗
23. 10.1016/j.polymer.2015.03.08010.1016/j.polymer.2015.03.080 ↗
24. 10.1021/ja107502510.1021/ja1075025 ↗
25. 10.1016/0006-291X(86)91029-610.1016/0006-291X(86)91029-6 ↗
26. 10.1016/j.bmc.2010.06.08410.1016/j.bmc.2010.06.084 ↗
27. 10.1158/0008-5472.CAN-11-311510.1158/0008-5472.CAN-11-3115 ↗